Abstract
There is considerable interest in dose to the breast in patients undergoing mantle treatment for Hodgkin's disease. This is because the patients are quite young (adolescents) and the latency period between irradiation and appearance of tumors is long. In a prospective study TLD chips were placed in several positions on the breast of the patients undergoing mantle treatment. Some parts of the breast were in the irradiated region. TLDs were placed under 2 and 3 cm of superflab bolus. Mantle field is irradiated with 10MV X-rays with a 2 cm spoiler placed 15 cm from the patient's skin. Treatment is given at 120 cm SAD. Doses in the range of 20–30 cGy per fraction were measured underneath the blocks in most cases, and doses of 30–50 cGy were measured at the edge of the block. The prescription is 200 cGy per fraction. The implication of these results will be discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.